Novel insights in the management and prognosis of pulmonary hypertension
ESC 2017 Prof. Galiè summarizes new results regarding pulmonary hypertension (PH) that were presented at ESC 2017, separately for each clinical PH group. Treatment options expand and some can improve patient outcomes.
Video navigation menu
- Group 1: Pulmonary Arterial Hypertension 0:28
- Group 2: PH due to left heart disease 2:16
- Group 3: PH due to lung disease 2:51
- Group 4: Chronic Thrombo-Embolic PH (CTEPH) 3:07
Prof Nazzareno Galiè, MD, heads the Pulmonary Hypertension Centre at the Institute of Cardiology and is Associate Professor of Cardiology at the Medical Faculty of the University of Bologna, Italy. He also teaches at the Postgraduate Medical Schools of Cardiology, Pulmonary Diseases, and Rheumatology at the University of Bologna. He is Director of the International Master Degree in Pulmonary Vascular Diseases of the University of Bologna. He is past-Chairman of the working group on pulmonary circulation of the European Society of Cardiology and of the joint task force of the European Society of Cardiology and the European Respiratory Society for the guidelines on pulmonary hypertension.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme. PACE-cme did not receive financial support for the production of this recording.